ANZCA is one of the largest specialist medical colleges in Australia and New Zealand, and the region's foremost authority on anaesthesia, pain and perioperative medicine.

We support research in anaesthesia, pain medicine and perioperative medicine to improve patient outcomes through funding and resources, collaboration, and networks. 

New this month: Alert update on periprocedural diabetic ketoacidosis (DKA) with SGLT2 inhibitor use in people with diabetes; neuraxial equipment changeover guidelines on website; and reporting regurgitations and aspiration events using webAIRS.

The Faculty of Pain Medicine says there needs to be more clinical evidence about the efficacy of medicinal cannabis before use as a treatment for chronic, non-cancer pain.

We're committed to improving education and training capacity in anaesthesia and pain medicine in response to the needs expressed by low and middle income countries (LMIC).

Updates include: PPRN webinar; Foundation supporter evening; 2024 research grants; global health challenges

Recently, the ANZCA Environmental Sustainability Network were invited to engage on behalf of the college with a consultation process for the National Health and Climate Strategy being developed by the Australian Government.

The Western Australian Therapeutic Advisory Group and the Western Australian Drug Evaluation Panel have endorsed the delisting of Desflurane from the WA Statewide Medicines Formulary.

Dr Min-Qi Lee knows all too well the impact of the postcode lottery of health on patients living in regional, rural and remote areas.

We're responsible for setting the standards of clinical practice for anaesthesia and pain medicine in Australia and New Zealand. Our activities include issuing safety alerts; developing professional documents; and overseeing incident reporting.